Enhancement of lymphoid cholinergic activity by PGD2 and its inhibition by ONO-PM-182, a novel DP receptor antagonist in MOLT-3 cells, a human leukemic T cell line

被引:0
|
作者
Sugita, Y [1 ]
Suenaga, A [1 ]
Fujii, T [1 ]
Kawashima, K [1 ]
机构
[1] Kyoritsu Coll Pharmaceut Sci, Dept Pharmacol, Tokyo 1058512, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:202P / 202P
页数:1
相关论文
共 4 条
  • [1] Enhancement of lymphoid cholinergic system by ONO-4819-CD, a novel prostaglandin EP4 receptor agonist, in MOLT-3 cells, a human leukemic T-cell line
    Suenaga, A
    Fujii, T
    Kawashima, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 119P - 119P
  • [2] Studies on regulation of lymphocytic cholinergic activity via DIP receptor (DPR)-mediated pathways in MOLT-3 cells, using BW245C and ONO-PM-182
    Sugita, Y
    Suenaga, A
    Fujii, T
    Kawashima, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 230P - 230P
  • [3] Up-regulation of lymphocytic cholinergic activity by ONO-4819, a selective prostaglandin EP4 receptor agonist, in MOLT-3 human leukemic T cells
    Suenaga, A
    Fujii, T
    Ogawa, H
    Maruyama, T
    Ohuchida, S
    Katsube, N
    Obata, T
    Kawashima, K
    VASCULAR PHARMACOLOGY, 2004, 41 (02) : 51 - 58
  • [4] Enhancement of an idependent, non-neuronal lymphocytic cholinergic system by cAMP in MOLT-3 cells, a human T cell line.
    Fujii, T
    Suenaga, A
    Kawashima, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 283P - 283P